Sunday November 8, 2009 3:14 AM ET
SmartMoney
Share Price ($): 
52.80
Price Change: 
0.22 (0.42%)
Last 10 Quotes
What is this?
NVS 
(NOVARTIS AG ADS)
Exchange: NYSE     Industry: Drug Manufacturers/Major
Last Trade 4:01 PM ET 11/6/2009
Click Here Click Here
Volume:1,175,455
Day's Low:$52.30
52-wk Low:$33.34
Previous Close:$52.58
Dividend:$1.72
Market Cap:119,581,400
Avg Volume: 1,343,100
Day's High:$52.81
52-wk High:$52.92
Open Price:$52.33
Yield: 3.26%
P/E (Forward): 14.59
Chart for NVS
After-Hours Trading:
Last Trade:4:12 PM
Price:52.65
Volume:1200
Breaking News
9:04 AM  11/6/2009   Generics Makers Line Up To Sell Copies Of Pfizer's Lipitor
4:18 PM  11/5/2009   Wall St Firms Shouldn't Get Scarce Flu Shots, Nonprofit Says
3:55 AM  11/5/2009   UPDATE: Novartis' Cell-Based Swine Flu Vaccine Gets German OK
3:19 AM  11/5/2009   Novartis Gets German OK For Cell-Based Swine Flu Vaccine
1:32 AM  11/5/2009   Novartis Receives German Approval For H1N1 Vaccine Celtura
1:30 AM  11/5/2009   PRESS RELEASE: Novartis Receives Regulatory Approval In Germany For Celtura&##174;, A Cell Culture-Based Influenza A(H1N1) Pandemic Vaccine
4:14 PM  11/4/2009   2nd UPDATE:H1N1 Vaccine Shortages Frustrating Health Officials
Stories & Blogs
11/6/2009  South Korean FDA Probes Roche for Aiding Tamiflu Stockpiling
11/5/2009  Flu Vaccine Update: Beyond Chicken Eggs; Seasonal Shortage
11/4/2009  Officials Frustrated by Vaccine Shortage
11/3/2009  Pharma's Hiring! (In China)
11/3/2009  J&J To Cut 7% of Workforce
10/29/2009  Booster Raises H1N1-Vaccine Bar
10/26/2009  Obama Declares Swine-Flu Emergency
Earnings & Forecast
Most Recent Quarter ($)Same Quarter Last Year ($)% Change
EPS, Pro Forma 0.92 0.92 0.00
EPS, GAAP 0.89 0.99 -10.10
Consensus Estimate 0.95 0.99 -4.04
Trailing 12 MonthsYear-Earlier Period% Change
EPS, Pro Forma NA 3.59 NA
EPS, GAAP 3.35 5.37 -37.62
Consensus Estimate NA NA NA
Key Statistics
NVSIndustry Average
P/E (TTM) 15.76 18.40
P/E (Forward) 14.59 -4.30
PEG Ratio 7.72 -0.28
Price/Sales 2.86 2.94
Beta 0.53 0.56
Advertisements
View Overview for: